| VELLAS, Bruno |
LO-MAPT, NCT03691519: Prevention of Cognitive Decline in Older Adults With Low Dha/Epa Index in Red Blood Cells |
|
|
| Completed | 3 | 774 | Europe | Omega-3 treatment, Dietary intervention, Placebo | University Hospital, Toulouse | Alzheimer Disease | 03/20 | 03/20 | | |
PERSON-AL, NCT04820127: Personalized Management of Psycho-behavioral Symptoms in Alzheimer's Disease: Impact on Health Resources Use |
|
|
| Recruiting | N/A | 668 | Europe | personalized care preceded by a standardized assessment | University Hospital, Toulouse | Alzheimer's Disease | 10/24 | 10/24 | | |
ICOPE Fr, NCT06676839: Effectiveness of the WHO ICOPE (Integrated Care for Older People) Program in Preventing Age-related Functional Decline: a 36-month Randomized Controlled Trial with a 24-month Extension: (ICOPE Trial.Fr) |
|
|
| Recruiting | N/A | 1000 | Europe | the complete ICOPE program | University Hospital, Toulouse | Ageing | 10/31 | 10/31 | | |
| Active, not recruiting | N/A | 345 | Europe | MRI and PET scan | University Hospital, Toulouse, MSDAVENIR | Frail Elderly | 01/26 | 12/26 | | |
| Recruiting | N/A | 1000 | Europe | The Inspire Bio-resource Research Platform for Healthy Aging | University Hospital, Toulouse, European Regional Development Fund | Biological Aging | 10/31 | 10/33 | | |
| Carrié, Didier |
PiCSO-AMI-V, NCT04958421: A Study to Evaluate Safety and Feasibility of PiCSO Therapy in Patients With ST Elevation Inferior Wall Myocardial Infarction. |
|
|
| Terminated | N/A | 25 | Europe | PiCSO Impulse System | Miracor Medical SA | STEMI - ST Elevation Myocardial Infarction, Inferior Wall Myocardial Infarction | 02/23 | 02/23 | | |
| Alric, Laurent |
| Active, not recruiting | 3 | 871 | Europe, Canada, Japan, US, RoW | Bepirovirsen, Placebo | GlaxoSmithKline, GlaxoSmithKline Research & Development Limited | Chronic Hepatitis B, Hepatitis B, Chronic | 11/25 | 05/26 | | |
NCT06233461: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease |
|
|
| Recruiting | 2 | 268 | Europe, Canada, Japan, US, RoW | TAK-279, Zasocitinib, Placebo | Takeda | Crohn's Disease | 09/26 | 07/27 | | |
| Completed | 2 | 62 | Europe, Canada, US, RoW | EP547, Placebo | Escient Pharmaceuticals, Inc, Escient Pharmaceuticals, Inc. | Pruritus | 07/24 | 09/24 | | |
LIVEDIFF, NCT06306014: Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients |
|
|
| Recruiting | 1/2 | 56 | Europe | EXL01, Placebo | Hospices Civils de Lyon, Exeliom Biosciences | Clostridioides Difficile Infection, Recurrent Infection | 01/27 | 01/27 | | |
PREPCOV, NCT04481633: Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection |
|
|
| Recruiting | N/A | 800 | Europe | COVID 19 serology, COVID 19 Self-Questionnaire | University Hospital, Toulouse | COVID-19 | 03/22 | 03/22 | | |
PROPLACO-Tel, NCT05641142: Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia |
|
|
| Recruiting | N/A | 100 | Europe | monitoring the use of anticoagulant and/or antiplatelet therapy in patients with osler rendering disease | University Hospital, Clermont-Ferrand | Hereditary Hemorrhagic Telangiectasia, Rendu Osler Disease | 05/25 | 01/27 | | |
| Recruiting | N/A | 400 | Europe | Questionnaire | Hospices Civils de Lyon | Vascular Anomaly, Osler Rendu Disease, Marfan Syndrome or Related, Lymphedema Primary, Arteriovenous Malformations, Cerebrospinal; Disorder | 02/27 | 11/28 | | |
| Recruiting | N/A | 800 | Europe | Blood draw for the laboratory assessment | ANRS, Emerging Infectious Diseases | Hepatitis D, Chronic, Hepatitis B, Chronic | 12/27 | 06/28 | | |
| BREFEL-COURBON, Christine |
| Active, not recruiting | 3 | 134 | Europe | Apomorphine, Apokinon, Best Medical Treatment | Rennes University Hospital | Parkinson's Disease | 12/23 | 01/25 | | |
NCT03940872: Primary Parkinsonian Pain Diagnostic Questionnaire: Development and Validation of This Questionnaire |
|
|
| Completed | N/A | 227 | Europe | Self-questionnaire 3PDQ | University Hospital, Toulouse | Parkinson Disease | 12/22 | 12/22 | | |
| Completed | N/A | 30 | Europe | reflexology massage, sham massage | University Hospital, Toulouse | Parkinson Disease | 05/23 | 05/23 | | |
GlutaTour, NCT03681795: Exploration of Glutamatergic System With PET Radiotracer in Gilles de la Tourette Patients: Pilot Study |
|
|
| Recruiting | N/A | 24 | Europe | Experimental MRI exam and PET scan exam with radiotracer | University Hospital, Toulouse | Tourette Syndrome | 12/23 | 12/24 | | |
| Recruiting | N/A | 100 | Europe | CSF, blood and urine sampling, clinical measures of disease severity and progression | University Hospital, Bordeaux | Parkinsonian Syndromes, Parkinson's Disease, Multiple System Atrophy, Progressive Supranuclear Palsy | 12/23 | 12/25 | | |
| Completed | N/A | 100 | Europe | TCI, BPI, CPAQ-8, SF-MPQ, King's Parkinson's Disease Pain Scale (KPPS), Hospital Anxiety and Depression scale (HAD) questionary, PCS, ORT, Social Support Questionnaire (SSQ6), IPQ-R, WCC-R | University Hospital, Toulouse | Parkinson Disease | 04/24 | 04/24 | | |
PD-Pain, NCT06008704: Pain in Parkinson's Disease: Exploration of the Serotonin System in Positron Emission Tomography (PET [18F]-MPPF) |
|
|
| Recruiting | N/A | 34 | Europe | Clinical assessment, Pain characteristics assessment, MRI, Thermotest, UPDRS-III Scale, [18F]-MPPF PET scan | University Hospital, Toulouse | Parkinson Disease | 09/26 | 09/26 | | |
| Gourdy, Pierre |
| Completed | 4 | 282 | Europe, US, RoW | Tirzepatide, LY3298176, Dulaglutide, LY2189265 | Eli Lilly and Company | Type 2 Diabetes | 07/24 | 08/24 | | |
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) |
|
|
| Recruiting | 3 | 10000 | Europe, Canada, US, RoW | Retatrutide, LY3437943, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD) | 02/29 | 02/29 | | |
| Active, not recruiting | 3 | 15374 | Europe, Canada, Japan, US, RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Obesity, Overweight | 10/27 | 10/27 | | |
| Completed | N/A | 130 | Europe | Glycemia estimated by exhaled air analyzer, Questionnaire, Veinous glycemia, Capillary glycemia, constitution biological collection, Blood sample, Test meal | University Hospital, Toulouse | Diabetes Mellitus, Type 2 | 02/23 | 02/23 | | |
STEATO-POMPE, NCT04270656: Liver and Metabolic Effects of Insulin Pump Therapy in Diabetics Type 2 with Non-alcoholic Hepatic Steatosis |
|
|
| Completed | N/A | 46 | Europe | Insulin pump therapy, Multi-injection treatment ( MDI ). | Nantes University Hospital, University Hospital, Angers | Type 2 Diabetes (T2D) | 09/24 | 09/24 | | |
ACTIDIANE, NCT03184662: Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 Diabetes |
|
|
| Recruiting | N/A | 300 | Europe | HIPA, Counseling PA | Poitiers University Hospital, University Hospital, Bordeaux, University Hospital, Clermont-Ferrand, Centre Hospitalier Universitaire Dijon, Centre Hospitalier Universitaire de Besancon, Hopital Lariboisière, Bichat Hospital, Centre Hospitalier Sud Francilien, University Hospital, Lille, Centre Hospitalier Universitaire de Nice, University Hospital, Caen, University Hospital, Toulouse, University Hospital, Tours, Nantes University Hospital, Groupe Hospitalier Pitie-Salpetriere, Hospices Civils de Lyon, University Hospital, Montpellier, University Hospital, Strasbourg, Central Hospital, Nancy, France, HOSPITAL, CHARTRES, University of Liege | Type2 Diabetes, Diabetic Kidney Disease | 09/23 | 12/23 | | |
GAP OUEST, NCT06185491: Assessment of HGI (Hemoglobin Glycation Index) Variability Over Time in Patients Living with Diabetes Using Continuous Glucose Monitoring ( ) |
|
|
| Recruiting | N/A | 750 | Europe | HGI | Nantes University Hospital | Diabetes Mellitus | 09/27 | 09/27 | | |
BOYDSENSE DATA, NCT06614101: Study Enabling the Collection of Clinical Data Necessary for the Second Phase of Development of the Glycemic Measurement Device by Analysis of Exhaled Air |
|
|
| Recruiting | N/A | 235 | Europe | Exhaled air analysis | University Hospital, Toulouse | Type 2 Diabetes | 05/26 | 05/26 | | |
GLUCOGEN, NCT06570278: Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes |
|
|
| Recruiting | N/A | 1020 | Europe | WGS coupled with MCM | Institut National de la Santé Et de la Recherche Médicale, France, Commissariat A L'energie Atomique, Rennes University Hospital, Central Hospital, Nancy, France, Nantes University Hospital, Imagine Institute, APHP, Hospices Civils de Lyon, Université Lumière Lyon 2, Toulouse University Hospital | Diabetes Mellitus | 11/31 | 11/34 | | |
| Recruiting | N/A | 348 | Europe | DBLG1 System | Diabeloop | Type1diabetes | 07/25 | 01/26 | | |
| Recruiting | N/A | 850 | Europe | Freestyle Libre Pro iQ | University Hospital, Montpellier | Acute Coronary Syndrome, Continuous Glucose Measurement, Glycemic Variability, Cardiovascular Event | 05/26 | 05/26 | | |
| Recruiting | N/A | 1000 | Europe, RoW | | University Hospital, Bordeaux, Fondation Francophone pour la Recherche sur le Diabete | Diabetic Foot Ulcer | 11/29 | 11/29 | | |
| CHARPENTIER, Sandrine |
e-CARE, NCT04157790: Efficacy of the CARE Rule Associated With the HEART Score in Patients With Emergency Chest Pain |
|
|
| Completed | N/A | 2153 | Europe | CARE score | University Hospital, Angers | Chest Pain | 05/23 | 09/23 | | |
| LAPEYRE-MESTRE, Maryse |
| Recruiting | N/A | 10000 | Europe | | University Hospital, Toulouse | Addiction | 04/23 | 04/23 | | |
| Recruiting | N/A | 10000 | Europe | Medical information | University Hospital, Toulouse | Thrombocytopenia | 05/23 | 05/23 | | |
| Melki, Vincent |
| Recruiting | N/A | 160 | Europe | Insulin Management System in Manual mode of operation, Insulin Management System in Automatic mode of operation | Medtrum France, Axonal-Biostatem | Type 1 Diabetes | 11/25 | 12/25 | | |
| Recruiting | N/A | 348 | Europe | DBLG1 System | Diabeloop | Type1diabetes | 07/25 | 01/26 | | |
| GEERAERTS, Thomas |
OPTIMIL, NCT04282629: Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia |
|
|
| Recruiting | 2 | 234 | Europe | Milrinone Injection, Placebo | University Hospital, Toulouse | Aneurysmal Subarachnoid Hemorrhage | 07/25 | 07/25 | | |
DETERMINE, NCT04352296: Effect of Individualized Versus Standard Bp Management During MT for Anterior Ischemic Stroke |
|
|
| Completed | N/A | 433 | Europe | Individualized blood pressure, Standard blood pressure | Fondation Ophtalmologique Adolphe de Rothschild, Ministry of Health, France | Acute Cerebrovascular Accident | 01/24 | 01/24 | | |
| Recruiting | N/A | 62 | Europe | alveolar recruitment maneuvers group 1, alveolar recruitment maneuvers group 2 | University Hospital, Toulouse | Cerebral Injuries, Acute Respiratory Distress Syndrome (ARDS) | 12/25 | 12/25 | | |
| Recruiting | N/A | 660 | Europe | Extubation readiness clinical score, Standard of care | University Hospital, Clermont-Ferrand, AZUREA Network (www.azurea.org), ANARLF Network, Direction Générale de l'Offre de Soin (DGOS) | Mechanical Ventilator Weaning, Acute Brain Injury, Altered Level of Consciousness, Mechanical Ventilation, Airway Control | 02/27 | 10/27 | | |
| Thalamas, Claire |
CORELIA, NCT03464344: Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy. |
|
|
| Recruiting | N/A | 170 | Europe | neurological, neuropsychological and MRI evaluation | University Hospital, Toulouse | Cerebral Amyloid Angiopathy | 02/23 | 02/25 | | |
| Recruiting | N/A | 62 | Europe | Overnight polysomnography, blood sample, high-resolution MRI scan, neuropsychological evaluation | University Hospital, Toulouse, Centre de Recherches sur la Cognition Animale (CRCA - UMR5169 CNRS/UPS), Centre de Recherche Cerveau & Cognition (CerCo - UMR5549 CNRS/UPS), Toulouse NeuroImaging Center (ToNIC - UMR 1214 Inserm/UPS), Fondation Plan Alzheimer, IHNPS/FHU HoPeS | Alzheimer Disease, Early Onset | 06/23 | 06/23 | | |
| Recruiting | N/A | 60 | Europe | Cerebral neuroinflammation evaluation | University Hospital, Toulouse, Institut National de la Santé Et de la Recherche Médicale, France | Depressive Disorder | 01/24 | 01/24 | | |
| LOZANO, Stéphanie |
LYMPHOLD, NCT05101759: Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy |
|
|
| Completed | N/A | 100 | Europe | Comprehensive Geriatric Assessment | University Hospital, Toulouse, Institut Claudius Regaud | Neoplasm, Plasma Cell, Lymphoma | 09/24 | 09/24 | | |
| Not yet recruiting | N/A | 30 | Europe | ICOPE Monitoring | University Hospital, Toulouse | Frailty, Multiple Myeloma | 09/26 | 09/26 | | |
| Georges, Bernard |
| Recruiting | 3 | 80 | Europe | 1 hour infusion, Zerbaxa 1 g/0.5 g powder, 4 hours infusion | University Hospital, Toulouse | Ventilator-associated Pneumonia | 02/25 | 02/25 | | |
| MOTTON, Stéphanie |
ONCOCOL01, NCT03534713: Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread |
|
|
| Recruiting | 3 | 310 | Europe | Carboplatin, Carbo, Paclitaxel, Taxol, Cisplatin, Platinol, Radiotherapy, radiation therapy | University Hospital, Toulouse, Institut Claudius Regaud | Cervical Cancer TNM Staging Regional Lymph Nodes (N) | 09/26 | 12/26 | | |
| Recruiting | N/A | 214 | Europe | Anterior colporraphy, vaginal patch plastron | University Hospital, Limoges | Prolapse, Vaginal | 09/25 | 03/28 | | |
PROGRESS, NCT05723471: Impact of a Collaborative Program of Physical Activity of Newly-diagnosed Cancer Patients |
|
|
| Not yet recruiting | N/A | 350 | Europe | Adaptative Physical Activity | University Hospital, Toulouse | Cancer | 10/27 | 12/27 | | |
| MAURY, Philippe |
| Recruiting | 2 | 120 | Europe | Spironolactone, Placebo | Hospices Civils de Lyon | Arrhythmogenic Right Ventricular Dysplasia | 12/27 | 12/29 | | |
FA2CM-DVDA, NCT03177018: DNA Analysis From Isolated Cardiomyocytes in the Molecular Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia |
|
|
| Completed | N/A | 34 | Europe | Cardiomyocytes collection | University Hospital, Toulouse | Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Right Ventricular Cardiomyopathy | 02/18 | 12/18 | | |
OPALE, NCT03058185: Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies) |
|
|
| Recruiting | N/A | 800 | Europe | | Pitié-Salpêtrière Hospital, Institute of Myology, Assistance Publique - Hôpitaux de Paris, Institut National de la Santé Et de la Recherche Médicale, France | Laminopathies, Emerinopathies | 07/33 | 07/33 | | |
| Recruiting | N/A | 80 | Europe | Peripheral immunological assessment on venous blood, Immunological assessment carried out on intracardiac material | University Hospital, Toulouse | Arrhythmogenic Right Ventricular Dysplasia | 02/26 | 02/26 | | |
| Recruiting | N/A | 20 | Europe | high resolution cartography | University Hospital, Toulouse | Atrioventricular Nodal Reentry Tachycardia, Supraventricular Tachycardia | 12/26 | 12/26 | | |
| Active, not recruiting | N/A | 292 | Europe, RoW | PVI using PEF, PVI using CFRF | University Hospital, Bordeaux, Funding: European Commission (H2020) | Atrial Fibrillation | 02/25 | 02/25 | | |
VIVA, NCT06294028: International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease with Minimally Impaired Ejection Fraction |
|
|
| Recruiting | N/A | 268 | Europe | Adverse events collection, Quality of life questionnaire EQ-5D-5L, Medical-economic evaluation | University Hospital, Toulouse | Ischemic Heart Disease, Ventricular Tachycardia | 12/29 | 12/29 | | |
| Completed | N/A | 119 | Europe | image-guided VT ablation strategy, conventional VT ablation strategy | University Hospital, Bordeaux, EIT Health | Ventricular Tachycardia | 12/23 | 12/24 | | |
| Recruiting | N/A | 78 | Europe, RoW | PVI and Linear lesion using PEF, PVI and Linear lesion using CFRF | University Hospital, Bordeaux, Horizon 2020 - European Commission | Atrial Fibrillation | 05/25 | 05/25 | | |
RESOUDRE, NCT06642168: Sudden Cardiac Arrest Related to Sport in Young and Value of the Genetic Assessment: a French Prospective Register |
|
|
| Recruiting | N/A | 80 | Europe | Whole exome sequencing to detect myocardial genetic mutations (SCA group only) | Rennes University Hospital | Sudden Cardiac Arrest, Sudden Cardiac Death | 01/28 | 01/28 | | |
| Recruiting | N/A | 50 | Europe | Cardioneuroablation | University Hospital, Bordeaux | Syncope, Vasovagal, Bradycardia, Heart Arrest | 01/26 | 01/26 | | |
NCT03737929: Hybrid Therapy and Heart Team for Atrial Fibrillation |
|
|
| Recruiting | N/A | 228 | Europe | Hybrid ablation, Percutaneous catheter ablation | University Hospital, Toulouse, AtriCure, Inc. | Atrial Fibrillation | 12/25 | 12/25 | | |
| Recruiting | N/A | 1800 | Europe, RoW | HD ECG, Conventional 12-lead ECG | University Hospital, Bordeaux | Ventricular Arrhythmias | 04/27 | 04/27 | | |
| BUSCAIL, Louis |
| Completed | 2 | 68 | Europe | Gene Therapy product CYL-02, CYL-02, Gemcitabine | University Hospital, Toulouse, BIOTHERAPY department of the clinical center of investigation- CIC 1436, Toulouse, InvivoGen Therapeutics | Pancreatic Adenocarcinoma | 06/22 | 06/22 | | |
| Recruiting | N/A | 1500 | Europe | Collection of biological samples | University Hospital, Toulouse | Pancreatic Adenocarcinoma | 11/26 | 11/26 | | |
| Recruiting | N/A | 300 | Europe | | University Hospital, Toulouse | Pancreatic Diseases | 12/27 | 12/27 | | |
| Huyghe, Eric |
| Completed | N/A | 50 | Europe | Questionnaires | University Hospital, Toulouse | Sexual Dysfunction | 09/22 | 01/23 | | |
| Completed | N/A | 120 | Europe | Low intensity choc waves therapy (active applicator), Sham (sham applicator) | Hopital Foch, Dornier MedTech Systems | Peyronie Disease, Penile Diseases | 05/24 | 05/24 | | |
Microsperm, NCT02773498: Comparison of Medical Results of Testicular Sperm Extraction by Conventional Surgery and Microsurgical Track |
|
|
| Terminated | N/A | 50 | Europe | conventional TESE, conventional surgery, Micro TESE, Microdissection surgery | University Hospital, Toulouse | Azoospermia | 01/21 | 12/23 | | |
| Completed | N/A | 30 | Europe | FRAnçaise du PEYronie's Disease QUESTionnaire | University Hospital, Toulouse | Peyronie Disease | 05/23 | 05/23 | | |
| Not yet recruiting | N/A | 15 | NA | Questionnaire | University Hospital, Toulouse | Sexual Dysfunction Male | 01/25 | 01/25 | | |
| Ysebaert, Loïc |
MorningLyte, NCT06284122: Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5 |
|
|
| Recruiting | 3 | 790 | Europe | Mosunetuzumab, Lenalidomide, Rituximab, Obinutuzumab, Cyclophosphamide, Doxorubicin, Vincristin, Prednisone, Bendamustin | The Lymphoma Academic Research Organisation, Lymphoma Study Association, Swiss Group for Clinical Cancer Research, Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | Follicular Lymphoma | 11/28 | 04/34 | | |
| Active, not recruiting | 2 | 67 | Europe | Obinutuzumab, gazyva, RO7082859, glofitamab | The Lymphoma Academic Research Organisation | Diffuse Large B-Cell Lymphoma Refractory, Refractory Indolent Adult Non-Hodgkin Lymphoma, Refractory Transformed B-cell Non-Hodgkin Lymphoma, Refractory Primary Mediastinal Large B-Cell Cell Lymphoma, Refractory Mantle Cell Lymphoma | 01/23 | 03/26 | | |
GLORIFY, NCT06186648: Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome |
|
|
| Recruiting | 2 | 40 | Europe | Glofitamab + Obinutuzumab | French Innovative Leukemia Organisation, Hoffmann-La Roche | Richter Syndrome | 03/26 | 03/27 | | |
STAIR, NCT04963946: STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia |
|
|
| Recruiting | 2 | 160 | Europe | Stop ACA, ACA Continuation | French Innovative Leukemia Organisation | Untreated Chronic Lymphocytic Leukemia | 01/26 | 08/28 | | |
NCT06588478: A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
|
|
| Recruiting | 2 | 249 | Europe, Canada, US, RoW | Pirtobrutinib | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 06/28 | 12/28 | | |
| Recruiting | 2 | 56 | Europe | Lacutamab, Gemcitabine, Oxaliplatine | The Lymphoma Academic Research Organisation, Innate Pharma | Peripheral T Cell Lymphoma, Relapse/Recurrence | 01/25 | 01/27 | | |
|
LAMSA2020, NCT04968015: Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission |
|
|
| Active, not recruiting | 2 | 134 | Europe | Cytarabine-Venetoclax Association, Cytarabine-Idarubicin Association | French Innovative Leukemia Organisation | Acute Myeloid Leukemia | 08/25 | 01/29 | | |
COVID19_LLC-MW, NCT04391946: Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19 |
|
|
| Completed | N/A | 162 | Europe | Data registry | French Innovative Leukemia Organisation, Institut de cancérologie Strasbourg Europe | Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease | 03/22 | 03/23 | | |
| Recruiting | N/A | 350 | Europe | | International Extranodal Lymphoma Study Group (IELSG) | Marginal Zone Lymphoma | 12/25 | 12/25 | | |
ALK-OBS, NCT03603847: Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma |
|
|
| Completed | N/A | 41 | Europe | | The Lymphoma Academic Research Organisation, Hôpital Necker-Enfants Malades, Fondation ARC, Pfizer, Takeda | Anaplastic Large Cell Lymphoma, ALK-Positive | 06/23 | 06/23 | | |
| Completed | N/A | 152 | Europe | | French Innovative Leukemia Organisation, Bristol-Myers Squibb | CLL, Relapsed, CLL, Refractory, Bruton Tyrosine Kinase Inhibitor, Small Lymphocytic Leukemia | 12/23 | 03/24 | | |
LYMPHOLD, NCT05101759: Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy |
|
|
| Completed | N/A | 100 | Europe | Comprehensive Geriatric Assessment | University Hospital, Toulouse, Institut Claudius Regaud | Neoplasm, Plasma Cell, Lymphoma | 09/24 | 09/24 | | |
EVEREST, NCT04985214: Assessment of the Quality of Life of Patients With Lymphomas Treated With Oral Therapy |
|
|
| Recruiting | N/A | 464 | Europe | Questionnaire | University Hospital, Toulouse | Quality of Life | 01/25 | 01/25 | | |
| Recruiting | N/A | 600 | Europe | Quality of life | University Hospital, Toulouse, Force Hémato, Hospitalidee | Lymphoma | 06/25 | 06/25 | | |
THEMIS, NCT05350826: Evaluation of the Ambulatory Medical Assistance Nurse Program in Chronic Lymphocytic Leukemia |
|
|
| Recruiting | N/A | 450 | Europe | Ambulatory medical assistance | University Hospital, Toulouse | Chronic Lymphoid Leukemia | 07/25 | 07/25 | | |
| Active, not recruiting | N/A | 60 | Europe | Patient with histologically confirmed diffuse large B-cell lymphoma with a planned first line treatment by R-CHOP. | Institut Claudius Regaud, AstraZeneca | Diffuse Large B-cell Lymphoma | 10/25 | 10/25 | | |
FOLLOW, NCT05590702: French Observational Study of Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in Real-World Settings |
|
|
| Recruiting | N/A | 1000 | Europe | First line therapy | French Innovative Leukemia Organisation, AbbVie, AstraZeneca, BeiGene, Janssen-Cilag Ltd. | CLL/SLL | 11/25 | 12/32 | | |
| Recruiting | N/A | 50 | Europe | | University Hospital, Clermont-Ferrand | Chronic Lymphocytic Leukemia, CLL, Progressive Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Relapsed Chronic Lymphocytic Leukemia | 03/27 | 03/27 | | |
| Recruiting | N/A | 6000 | Europe | Real-life epidemiological platform of lymphoma in France | Hospices Civils de Lyon, The Lymphoma Academic Research Organisation | Diffuse Large B Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), T-cell Lymphoma (T-NHL), Hodgkin's Lymphoma (HL), Burkitt Lymphoma (BL)) | 11/27 | 11/27 | | |
| Recruiting | N/A | 204 | Europe | Chemotherapy + follow up, Chemotherapy + ASCT + follow up | Hospices Civils de Lyon | Peripheral T Cell Lymphoma | 04/28 | 04/28 | | |
| Recruiting | N/A | 500 | Europe | | French Innovative Leukemia Organisation | Waldenstrom's Disease, Prognostic Index | 06/30 | 06/30 | | |
| SILVA, Stein |
| Completed | N/A | 7 | Europe | serology testing profiles description, biomarkers, immune response characterization, in vivo brain PET-TSPO acquisitions, brain MRI assessment, neurocognitive assessment | University Hospital, Toulouse, Institut National de la Santé Et de la Recherche Médicale, France | Covid19, Delirium, Post-traumatic Stress Disorder | 06/22 | 06/22 | | |
ARISE, NCT06617377: Combined Whole-brain Structural and Functional MRI for the Prediction of Neurological Recovery After Cardiac Arrest |
|
|
| Not yet recruiting | N/A | 263 | NA | advanced whole-brain sMRI/fMRI/contrast-enhanced MRI scan | University Hospital, Toulouse | Coma, Cardiac Arrest, Disorder of Consciousness, Neurologic Disorder | 07/28 | 07/28 | | |
| SACCO, Guillaume |
| Recruiting | 2 | 282 | Europe, Canada, US, RoW | GSK4527226, Placebo | GlaxoSmithKline, Alector Inc. | Alzheimer's Disease | 12/26 | 02/29 | | |
| Recruiting | N/A | 170 | Europe | MBI-C Scale in French | University Hospital, Toulouse | Subjective Cognitive Complaint, Mild Cognitive Impairment, Neuropsychiatric Symptoms | 07/25 | 07/25 | | |
| Recruiting | N/A | 30 | Europe | speech therapy | Centre Hospitalier Universitaire de Nice | Stroke | 11/24 | 03/25 | | |
| Completed | N/A | 200 | Europe | Ultrasound measurement | Centre Hospitalier Universitaire de Nice | Sarcopenia | 08/23 | 08/23 | | |
| Recruiting | N/A | 34 | Europe | APA, PAE | Centre Hospitalier Universitaire de Nice | Neurocognitive Disorders | 11/24 | 11/25 | | |
